Results 271 to 280 of about 158,206 (306)
Some of the next articles are maybe not open access.
Glia, 2000
In the cerebellum of adult mammals, glial fibrillary acidic protein (GFAP) and vimentin (VIM) are coexpressed in Golgi epithelial cells (GEC), also known as Bergmann glia. In this study we used three transgenic knockout mice (GFAP, VIM and double GFAP and VIM) to analyze the involvement of these proteins in the building of glial filaments and in neuron-
M, Giménez Y Ribotta +3 more
openaire +2 more sources
In the cerebellum of adult mammals, glial fibrillary acidic protein (GFAP) and vimentin (VIM) are coexpressed in Golgi epithelial cells (GEC), also known as Bergmann glia. In this study we used three transgenic knockout mice (GFAP, VIM and double GFAP and VIM) to analyze the involvement of these proteins in the building of glial filaments and in neuron-
M, Giménez Y Ribotta +3 more
openaire +2 more sources
GFAP IgG associated inflammatory polyneuropathy
Journal of Neuroimmunology, 2020GFAP (glial fibrillary acidic protein)-IgG is predominantly associated with meningoencephalomyelitis, and neuropathy presentations are rare.We reviewed clinical, electrodiagnostic and histopathological presentations of GFAP-IgG associated peripheral neuropathy.We identified six cases, five of whom had peripheral neuropathy as the initial presentation ...
Pritikanta, Paul +7 more
openaire +2 more sources
Microscopy Research and Technique, 2004
AbstractSensory mechanisms in teeth are not well understood and may involve pulpal–neural interactions. Tooth cells that proliferate in vitro have polyclonal immunoreactivity (IR) for glial fibrillary acidic protein (GFAP), growth‐associated protein (GAP‐43), and vimentin, plus glial‐like ion channels.
Margaret R, Byers +3 more
openaire +2 more sources
AbstractSensory mechanisms in teeth are not well understood and may involve pulpal–neural interactions. Tooth cells that proliferate in vitro have polyclonal immunoreactivity (IR) for glial fibrillary acidic protein (GFAP), growth‐associated protein (GAP‐43), and vimentin, plus glial‐like ion channels.
Margaret R, Byers +3 more
openaire +2 more sources
1999
Abstract GFAP, glial fibrilfary acidic protein, is a member of the intermediate filament protein superfamily. It is expressed almost exclusively in astrocytes of the CNS but is also found in some cells of the PNS such as non-myelinating Schwann cells. GFAP is extensively used in histology and pathology as a cell-type marker.
openaire +1 more source
Abstract GFAP, glial fibrilfary acidic protein, is a member of the intermediate filament protein superfamily. It is expressed almost exclusively in astrocytes of the CNS but is also found in some cells of the PNS such as non-myelinating Schwann cells. GFAP is extensively used in histology and pathology as a cell-type marker.
openaire +1 more source
The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases
Glial fibrillary acidic protein (GFAP) is a well-established biomarker of reactive astrogliosis in the central nervous system because of its elevated levels following brain injury and various neurological disorders. The advent of ultra-sensitive methods for measuring low-abundant proteins has significantly enhanced our understanding of GFAP levels in ...
Dea Gogishvili +2 more
exaly +3 more sources
Anaplasia and Heterogeneity of Gfap Expression in Gliomas
Tumori Journal, 1986GFAP (glial fibrillary acidic protein) distribution was investigated in selected areas of glioblastomas and astrocytomas. The proliferating cell population of glioblastomas was GFAP negative and contained many mitoses which were also negative. The old, deeply located areas were composed of cells with visible cytoplasm, intensely GFAP-positive; mitoses
SCHIFFER D. +3 more
openaire +3 more sources
Clinical characteristics of autoimmune GFAP astrocytopathy
Journal of Neuroimmunology, 2019The clinical features of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy remain to be elucidated. We describe here the clinical features of 14 patients with GFAP astrocytopathy confirmed by detection of GFAP-IgG in cerebrospinal fluid (CSF). The novel findings of this study are as follows.
Akio, Kimura +4 more
openaire +2 more sources
Acta Neurologica Scandinavica, 2009
A solid-phase radioimmunoassay was developed for the detection of glial fibrillary acidic protein (GFAP) and GFAP-specific immunoglobulin G (IgG) antibodies. In antibody assays purified GFAP was absorbed onto polystyrene beads, followed by incubation in dilutions of serum.
J, Ruutiainen +4 more
openaire +2 more sources
A solid-phase radioimmunoassay was developed for the detection of glial fibrillary acidic protein (GFAP) and GFAP-specific immunoglobulin G (IgG) antibodies. In antibody assays purified GFAP was absorbed onto polystyrene beads, followed by incubation in dilutions of serum.
J, Ruutiainen +4 more
openaire +2 more sources
Surgical Neurology, 1991
The proliferative potential of two types of tumor cells that did or did not express glial fibrillary acidic protein (GFAP) in 19 cases of high-grade gliomas, including nine anaplastic astrocytomas (WHO criteria, grade 3) and 10 glioblastoma multiforme (grade 4), was investigated by a combined staining technique, one-step silver colloid method for ...
A, Hara +6 more
openaire +2 more sources
The proliferative potential of two types of tumor cells that did or did not express glial fibrillary acidic protein (GFAP) in 19 cases of high-grade gliomas, including nine anaplastic astrocytomas (WHO criteria, grade 3) and 10 glioblastoma multiforme (grade 4), was investigated by a combined staining technique, one-step silver colloid method for ...
A, Hara +6 more
openaire +2 more sources
GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Cells, 2023Ka Young Kim, Keun-A Chang
exaly

